ChiRex (CHRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ChiRex (CHRX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dick Roy who wrote (29)	3/25/1997 4:48:00 PM
From: Haseltine	of 130

Congratulations! You called it right. Based on today's 1.7 MM shares and almost $2/share increase, there is renewed interest in the stock. Based on their literature (<a href="http://www.tripeak.com/Chirex" ChiRex Inc.></a>), ChiRex does both asymmetric synthesis and enzymatic resolutions which make its technology broadly applicable across the industry. But more importantly, they have a 30 year history of manufacturing expertise (used to be part of Sterling Drug) so they really know what they are doing. All the factors are favorable for long term growth investment: trend to outsourcing in pharma industry, new drugs are chiral (technology differentiation should help bring in new business), elimination of Sepracor overhang, strong earnings growth. Do you have any other "finds" like this one?!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next